CX Institutional’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Sell |
480
-42
| -8% | -$2.89K | ﹤0.01% | 911 |
|
|
2025
Q1 | $36K | Buy |
+522
| New | +$36K | ﹤0.01% | 884 |
|
|
2022
Q3 | – | Sell |
-1,000
| Closed | -$56K | – | 919 |
|
|
2022
Q2 | $56K | Buy |
+1,000
| New | +$56K | ﹤0.01% | 654 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$48K | – | 731 |
|
|
2021
Q3 | $48K | Hold |
1,000
| – | – | ﹤0.01% | 589 |
|
|
2021
Q2 | $42K | Hold |
1,000
| – | – | ﹤0.01% | 593 |
|
|
2021
Q1 | $34K | Hold |
1,000
| – | – | ﹤0.01% | 568 |
|
|
2020
Q4 | $35K | Hold |
1,000
| – | – | ﹤0.01% | 503 |
|
|
2020
Q3 | $35K | Hold |
1,000
| – | – | ﹤0.01% | 447 |
|
|
2020
Q2 | $33K | Sell |
1,000
-2,000
| -67% | -$66K | ﹤0.01% | 376 |
|
|
2020
Q1 | $90K | Buy |
+3,000
| New | +$90K | 0.01% | 276 |
|